Atonarp secure $8M to further develop its cancer-detecting spectrometer

Atonarp secures $8M to further develop its cancer-detecting spectrometer

Tokyo-based company made a device that can analyze a user's breath to non-invasively detect early phase cancer; the round was led by Walden Riverwood Ventures.